Is BIO Key Stock a Good Investment?
BIO Key Investment Advice | BKYI |
- Examine BIO Key's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research BIO Key's leadership team and their track record. Good management can help BIO Key navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Systems Software space and any emerging trends that could impact BIO Key's business and its evolving consumer preferences.
- Compare BIO Key's performance and market position to its competitors. Analyze how BIO Key is positioned in terms of product offerings, innovation, and market share.
- Check if BIO Key pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about BIO Key's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in BIO Key International stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if BIO Key International is a good investment.
Sell | Buy |
Strong Sell
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Undervalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Investor Sentiment | Excited | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Poor | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine BIO Key Stock
Researching BIO Key's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company recorded a loss per share of 8.66. BIO Key International last dividend was issued on the 20th of November 2020. The entity had 1:18 split on the 21st of December 2023.
To determine if BIO Key is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding BIO Key's research are outlined below:
| BIO Key is way too risky over 90 days horizon | |
| BIO Key has some characteristics of a very speculative penny stock | |
| BIO Key appears to be risky and price may revert if volatility continues | |
| BIO Key has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 7.75 M. Net Loss for the year was (8.52 M) with profit before overhead, payroll, taxes, and interest of 3.44 M. | |
| BIO Key International currently holds about 4.89 M in cash with (3.79 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.58. | |
| BIO Key has a poor financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: ARMISTICE CAPITAL, LLC Acquires New Stake in BIO-key International Inc |
BIO Key uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in BIO Key International. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to BIO Key's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 29th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
Earnings surprises can significantly impact BIO Key's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises BIO Key's investors have experienced.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2021-11-15 | 2021-09-30 | -0.11 | -0.13 | -0.02 | 18 | ||
2021-03-25 | 2020-12-31 | -0.16 | -0.18 | -0.02 | 12 | ||
2021-08-16 | 2021-06-30 | -0.11 | -0.15 | -0.04 | 36 | ||
2017-05-15 | 2017-03-31 | -0.22 | -0.26 | -0.04 | 18 | ||
2023-08-14 | 2023-06-30 | -0.23 | -0.16 | 0.07 | 30 | ||
2021-05-14 | 2021-03-31 | -0.16 | -0.09 | 0.07 | 43 | ||
2022-05-16 | 2022-03-31 | -0.22 | -0.12 | 0.1 | 45 | ||
2022-03-29 | 2021-12-31 | -0.15 | -0.26 | -0.11 | 73 |
Know BIO Key's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as BIO Key is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading BIO Key International backward and forwards among themselves. BIO Key's institutional investor refers to the entity that pools money to purchase BIO Key's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Abich Financial Wealth Management Llc | 2024-09-30 | 0.0 | Group One Trading, Lp | 2024-06-30 | 0.0 | Geode Capital Management, Llc | 2024-09-30 | 0.0 | Armistice Capital, Llc | 2024-09-30 | 250 K | Tower Research Capital Llc | 2024-06-30 | 5.9 K | Ubs Group Ag | 2024-06-30 | 2.4 K | Advisor Group Holdings, Inc. | 2024-06-30 | 262 | Jpmorgan Chase & Co | 2024-06-30 | 71.0 | Headlands Technologies Llc | 2024-09-30 | 16.0 | Bank Of America Corp | 2024-06-30 | 14.0 | Harbour Investments, Inc. | 2024-09-30 | 6.0 |
BIO Key's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 3.25 M.Market Cap |
|
BIO Key's profitablity analysis
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (2.74) | (2.88) | |
| Return On Capital Employed | (6.77) | (6.43) | |
| Return On Assets | (1.89) | (1.98) | |
| Return On Equity | (8.01) | (7.61) |
Determining BIO Key's profitability involves analyzing its financial statements and using various financial metrics to determine if BIO Key is a good buy. For example, gross profit margin measures BIO Key's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of BIO Key's profitability and make more informed investment decisions.
Evaluate BIO Key's management efficiency
BIO Key International has return on total asset (ROA) of (0.5568) % which means that it has lost $0.5568 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (4.5811) %, meaning that it created substantial loss on money invested by shareholders. BIO Key's management efficiency ratios could be used to measure how well BIO Key manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -2.88. The BIO Key's current Return On Capital Employed is estimated to increase to -6.43. As of now, BIO Key's Intangibles To Total Assets are decreasing as compared to previous years. The BIO Key's current Fixed Asset Turnover is estimated to increase to 31.17, while Total Assets are projected to decrease to under 4.3 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 1.90 | 1.99 | |
| Tangible Book Value Per Share | (0.61) | (0.65) | |
| Enterprise Value Over EBITDA | (0.20) | (0.19) | |
| Price Book Value Ratio | 1.58 | 1.66 | |
| Enterprise Value Multiple | (0.20) | (0.19) | |
| Price Fair Value | 1.58 | 1.66 | |
| Enterprise Value | 5 M | 4.7 M |
The strategic vision of BIO Key International management plays a critical role in its financial performance. By evaluating this vision, we provide insights into the stock's growth potential.
Beta 0.245 |
Basic technical analysis of BIO Stock
As of the 26th of November, BIO Key shows the mean deviation of 8.38, and Risk Adjusted Performance of 0.0314. BIO Key International technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.BIO Key's insider trading activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BIO Key insiders, such as employees or executives, is commonly permitted as long as it does not rely on BIO Key's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases BIO Key insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
BIO Key's Outstanding Corporate Bonds
BIO Key issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. BIO Key International uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most BIO bonds can be classified according to their maturity, which is the date when BIO Key International has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| BIOGEN INC 52 Corp BondUS09062XAD57 | View | |
| BIOGEN INC 405 Corp BondUS09062XAF06 | View | |
| BIOGEN INC Corp BondUS09062XAG88 | View | |
| BIOGEN INC Corp BondUS09062XAH61 | View | |
| BIIB 325 15 FEB 51 Corp BondUS09062XAK90 | View | |
| MGM Resorts International Corp BondUS552953CD18 | View |
Understand BIO Key's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing BIO Key's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
| Risk Adjusted Performance | 0.0314 | |||
| Market Risk Adjusted Performance | (0.47) | |||
| Mean Deviation | 8.38 | |||
| Semi Deviation | 8.32 | |||
| Downside Deviation | 8.91 | |||
| Coefficient Of Variation | 3505.34 | |||
| Standard Deviation | 17.34 | |||
| Variance | 300.57 | |||
| Information Ratio | 0.0211 | |||
| Jensen Alpha | 0.6056 | |||
| Total Risk Alpha | (2.21) | |||
| Sortino Ratio | 0.0411 | |||
| Treynor Ratio | (0.48) | |||
| Maximum Drawdown | 124.43 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 18.31 | |||
| Downside Variance | 79.44 | |||
| Semi Variance | 69.24 | |||
| Expected Short fall | (12.01) | |||
| Skewness | 4.08 | |||
| Kurtosis | 20.32 |
| Risk Adjusted Performance | 0.0314 | |||
| Market Risk Adjusted Performance | (0.47) | |||
| Mean Deviation | 8.38 | |||
| Semi Deviation | 8.32 | |||
| Downside Deviation | 8.91 | |||
| Coefficient Of Variation | 3505.34 | |||
| Standard Deviation | 17.34 | |||
| Variance | 300.57 | |||
| Information Ratio | 0.0211 | |||
| Jensen Alpha | 0.6056 | |||
| Total Risk Alpha | (2.21) | |||
| Sortino Ratio | 0.0411 | |||
| Treynor Ratio | (0.48) | |||
| Maximum Drawdown | 124.43 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 18.31 | |||
| Downside Variance | 79.44 | |||
| Semi Variance | 69.24 | |||
| Expected Short fall | (12.01) | |||
| Skewness | 4.08 | |||
| Kurtosis | 20.32 |
Consider BIO Key's intraday indicators
BIO Key intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of BIO Key stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
BIO Key time-series forecasting models is one of many BIO Key's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary BIO Key's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.
BIO Stock media impact
Far too much social signal, news, headlines, and media speculation about BIO Key that are available to investors today. That information is available publicly through BIO media outlets and privately through word of mouth or via BIO internal channels. However, regardless of the origin, that massive amount of BIO data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of BIO Key news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of BIO Key relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to BIO Key's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive BIO Key alpha.
BIO Key Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards BIO Key can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
BIO Key Corporate Management
| Cecilia Welch | Chief Officer | Profile | |
| Akintunde Jeje | Managing Africa | Profile | |
| Alex Rocha | Managing EMEA | Profile | |
| Mira LaCous | Chief Officer | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in BIO Key International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Is Systems Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BIO Key. If investors know BIO will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BIO Key listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (8.66) | Revenue Per Share 6.323 | Quarterly Revenue Growth (0.41) | Return On Assets (0.56) | Return On Equity (4.58) |
The market value of BIO Key International is measured differently than its book value, which is the value of BIO that is recorded on the company's balance sheet. Investors also form their own opinion of BIO Key's value that differs from its market value or its book value, called intrinsic value, which is BIO Key's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BIO Key's market value can be influenced by many factors that don't directly affect BIO Key's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between BIO Key's value and its price, as these two are different measures arrived at by various means. Investors typically determine if BIO Key is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BIO Key's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.